Literature DB >> 1603332

Direct and indirect actions of morphine on medullary neurons that modulate nociception.

M M Heinricher1, M M Morgan, H L Fields.   

Abstract

The rostral ventromedial medulla is part of a neural network through which systemically administered morphine produces antinociception. Two physiologically characterized classes of presumed nociceptive modulating neurons that respond differentially to systemically administered morphine have been identified in this region: the firing of "on-cells" is depressed, whereas "off-cells" become continuously active. On-cells have been proposed to permit or facilitate, and off-cells to inhibit, nociceptive transmission. Because local application of morphine in the rostral ventromedial medulla itself is sufficient to produce antinociception, it is important to determine whether systemically administered morphine exerts its effects on neurons in this region by a direct action. Thus, activity of physiologically characterized neurons was studied before, during and after ionotophoretic administration of morphine. As with systemic administration, iontophoretic application of morphine depresses the activity of on-cells, an effect that is reversed by iontophoretic as well as by systemic administration of naloxone. In contrast, no reliable changes in the firing of off-cells are produced by iontophoretic administration of morphine. Cells of a third class, "neutral cells", are not affected by systemic morphine administration, nor do they respond to iontophoretic application of the drug. The present experiments demonstrate that direct opioid responsiveness in the rostral ventromedial medulla is limited to a single physiologically characterized class of presumed nociceptive modulatory neuron, the on-cell. This implies that the antinociceptive effect exerted by systemically administered morphine involves at least two components within the rostral ventromedial medulla: a direct inhibition of on-cells, and an indirect activation of off-cells. Each of these actions is likely to have a net hypoalgesic effect.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1603332     DOI: 10.1016/0306-4522(92)90400-v

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  51 in total

1.  Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor.

Authors:  F Porreca; S E Burgess; L R Gardell; T W Vanderah; T P Malan; M H Ossipov; D A Lappi; J Lai
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  Physiological basis for inhibition of morphine and improgan antinociception by CC12, a P450 epoxygenase inhibitor.

Authors:  Mary M Heinricher; Jennifer J Maire; Delaina Lee; Julia W Nalwalk; Lindsay B Hough
Journal:  J Neurophysiol       Date:  2010-10-06       Impact factor: 2.714

3.  Sensory suppression during feeding.

Authors:  H Foo; Peggy Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

4.  Are opioid-sensitive neurons in the rostral ventromedial medulla inhibitory interneurons?

Authors:  D R Cleary; M J Neubert; M M Heinricher
Journal:  Neuroscience       Date:  2007-11-04       Impact factor: 3.590

5.  The role of the thalamus in modulating pain.

Authors:  Che Badariah Ab Aziz; Asma Hayati Ahmad
Journal:  Malays J Med Sci       Date:  2006-07

Review 6.  Review of overlap between thermoregulation and pain modulation in fibromyalgia.

Authors:  Alice A Larson; José V Pardo; Jeffrey D Pasley
Journal:  Clin J Pain       Date:  2014-06       Impact factor: 3.442

Review 7.  Central modulation of pain.

Authors:  Michael H Ossipov; Gregory O Dussor; Frank Porreca
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

8.  Adaptations in responsiveness of brainstem pain-modulating neurons in acute compared with chronic inflammation.

Authors:  Daniel R Cleary; Mary M Heinricher
Journal:  Pain       Date:  2013-02-28       Impact factor: 6.961

Review 9.  Descending control of nociception: Specificity, recruitment and plasticity.

Authors:  M M Heinricher; I Tavares; J L Leith; B M Lumb
Journal:  Brain Res Rev       Date:  2008-12-25

10.  Placebo and Active Treatment Additivity in Placebo Analgesia: Research to Date and Future Directions.

Authors:  Matthew J Coleshill; Louise Sharpe; Luana Colloca; Robert Zachariae; Ben Colagiuri
Journal:  Int Rev Neurobiol       Date:  2018-08-06       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.